IRWD
Ironwood Pharmaceuticals Inc
Price:  
9.07 
USD
Volume:  
15,931,332.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IRWD Relative Valuation

-1798.7%
Upside

As of 2024-03-04, the Relative Valuation of Ironwood Pharmaceuticals Inc (IRWD) is (153.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.07 USD, the upside of Ironwood Pharmaceuticals Inc based on Relative Valuation is -1798.7%.

The range of the Relative Valuation is (135.10) - (173.65) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 21.1x - 28.0x 24.8x
Forward P/E multiples 19.0x - 27.1x 23.2x
Fair Price (135.10) - (173.65) (153.99)
Upside -1590.4% - -2015.6% -1798.7%
9.07 USD
Stock Price
(153.99) USD
Fair Price

IRWD Relative Valuation - Historical P/E Data

Date P/E
2024-03-04 -1.47
2024-03-01 -1.42
2024-02-29 -1.47
2024-02-28 -2.36
2024-02-27 -2.37
2024-02-26 -2.35
2024-02-23 -2.35
2024-02-22 -2.32
2024-02-21 -2.36
2024-02-20 -2.32
2024-02-16 -2.28
2024-02-15 -2.34
2024-02-14 -2.41
2024-02-13 -2.37
2024-02-12 -2.40
2024-02-09 -2.39
2024-02-08 -2.33
2024-02-07 -2.32
2024-02-06 -2.32
2024-02-05 -2.30
2024-02-02 -2.28
2024-02-01 -2.28
2024-01-31 -2.22
2024-01-30 -2.16
2024-01-29 -2.15
2024-01-26 -2.09
2024-01-25 -2.12
2024-01-24 -2.08
2024-01-23 -2.11
2024-01-22 -2.05
2024-01-19 -1.98
2024-01-18 -1.90
2024-01-17 -1.93
2024-01-16 -1.83
2024-01-12 -1.90
2024-01-11 -1.91
2024-01-10 -1.94
2024-01-09 -1.95
2024-01-08 -1.99
2024-01-05 -1.94
2024-01-04 -1.94
2024-01-03 -1.92
2024-01-02 -1.94
2023-12-29 -1.79
2023-12-28 -1.79
2023-12-27 -1.80
2023-12-26 -1.76
2023-12-22 -1.75
2023-12-21 -1.73
2023-12-20 -1.72